Abstract:Damage to the lung in respiratory disease involves complex interactions in the lung micro‐environment. Such interactions involve different cell types (epithelial, mesenchymal, and immune cells) and mechanical forces (shear flow, pressure, and stretch). Traditional in vitro models, which are static and predominantly contain only one cell lineage, lack these interactions, limiting their physiological relevancy. Here, we present a new Airway Lung‐Chip platform for studying airway epithelial cell biology in the context of mechanical stimulation and endothelial co‐culture. We hypothesized that breathing‐like stretch and directional airflow would modulate epithelial tissue thickness, cellular composition, and differentiation. To assess this hypothesis, we first developed a multi‐step membrane functionalization method to overcome challenges hampering epithelial‐endothelial co‐cultures on stretchable, porous membranes at the air liquid interface. Such challenges included poor cell adhesion and undesired cellular migration between compartments. This optimized Airway Lung‐Chip was then used to systematically explore the effect of biomechanical stretch mimicking the force and frequency of physiological breathing, as well as airflow, on the differentiation of primary human airway epithelial cells, in the presence or absence of an endothelial lining. Our preliminary results from probing genetic, cellular, and functional markers of epithelial cell types as well as histological sections of the tissue indicate that basal cells exposed to airflow and stretch differentiate towards a more small‐airway like phenotype, containing few goblet cells and increased distribution of club cells, as compared to paired control chips. In conclusion, we have developed and optimized a new Airway Lung‐Chip model that represents a more physiological model of the human airway for in vitro studies. Our data also indicate that biomechanical forces, such as stretch and directional airflow, can influence airway stem cell differentiation which may have important implications in developing models of ventilation or when studying mechanisms driving airway disease.

Advances of microfluidic lung chips for assessing atmospheric pollutants exposure

Assessment of Air Pollutant PM2.5 Pulmonary Exposure Using a 3D Lung-on-Chip Model

Air Quality Effects on Human Health and Approaches for Its Assessment through Microfluidic Chips

A Microfluidic Lung-on-a-chip Based on Biomimetic Hydrogel Membrane

Airway-On-A-Chip: Designs and Applications for Lung Repair and Disease

Microfluidic Liquid-Air Dual-Gradient Chip for Synergic Effect Bio-Evaluation of Air Pollutant.

Sentinel supervised lung-on-a-chip: A new environmental toxicology platform for nanoplastic-induced lung injury

Development of alveolar-capillary-exchange (ACE) chip and its application for assessment of PM2.5-induced toxicity

Biomimetic microfluidic chips for toxicity assessment of environmental pollutants

Physiological and Disease Models of Respiratory System Based on Organ-on-a-Chip Technology

Recapitulating essential pathophysiological characteristics in lung-on-a-chip for disease studies

Recent Advances on Bioaerosol Collection and Detection in Microfluidic Chips

In vitro assessment of ferroptosis of cells exposed to cigarette smoke aerosol using a self-designed on-chip evaluation system based on gas-liquid dual-dimensional exposure

Reconstituting organ-level lung functions on a chip

Application of Microfluidic Chips in the Detection of Airborne Microorganisms

Evaluation of cigarette smoke-induced oxidative stress and inflammation in BEAS-2B cells based on a lung microfluidic chip

Advancements in Preclinical Human-Relevant Modeling of Pulmonary Vasculature On-Chip

A Modular Human Airway Lung‐Chip for Studying the Effect of Breathing‐Mechanics on Airway Epithelial Cell Biology

A lung/liver-on-a-chip platform for acute and chronic toxicity studies

A bronchiole-on-a-chip and a stretching system for studying human disease model of asthma attack

Progress and application of lung-on-a-chip for lung cancer